Anti-ganglioside antibodies alter presynaptic release and calcium influx

Neurobiology of Disease

Volumn 28, Issue 1, 2007, Pages 113-121

  Buchwald, Brigitte ^a,c   Zhang, Gang ^b,e   Vogt Eisele, Angela K ^d   Zhang, Weiyi ^d   Ahangari, Raheleh ^c   Griffin, John W ^b   Hatt, Hanns ^d   Toyka, Klaus V ^c   Sheikh, Kazim A ^b  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d RUHR UNIVERSITY BOCHUM   (Germany)

^e HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

AMAN; Anti ganglioside antibodies; Calcium influx; Gangliosides; Guillain Barr syndrome; Immune neuropathies; Neuromuscular junction

Indexed keywords

CALCIUM ION; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GD 1A; GANGLIOSIDE GD 1A ANTIBODY; GANGLIOSIDE GD 1B; GANGLIOSIDE GD 1B ANTIBODY; GANGLIOSIDE GM1; GANGLIOSIDE GM1 ANTIBODY; GANGLIOSIDE GT 1B; GANGLIOSIDE GT 1B ANTIBODY; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CALCIUM MOBILIZATION; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; GUILLAIN BARRE SYNDROME; IMMUNOPATHOGENESIS; MOUSE; MUSCLE WEAKNESS; NERVE CELL CULTURE; NEUROMUSCULAR SYNAPSE; NEUROTRANSMITTER RELEASE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; AUTOANTIGENS; CALCIUM; CELLS, CULTURED; DIAPHRAGM; GANGLIOSIDES; MICE; MICE, INBRED BALB C; NEUROMUSCULAR JUNCTION; NEURONS; NEUROTRANSMITTER AGENTS; OLFACTORY BULB; ORGAN CULTURE TECHNIQUES; PATCH-CLAMP TECHNIQUES; PERIPHERAL NERVOUS SYSTEM DISEASES; PRESYNAPTIC TERMINALS; SYNAPTIC TRANSMISSION;

EID: 34548714634     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2007.07.008     Document Type: Article

References (40)

1. Brewer G.J., Torricelli J.R., Evege E.K., and Price P.J. Optimized Survival of hippocampal-neurons in B27-supplemented neurobasal (Tm), a new serum-free medium combination. J. Neurosci. Res. 35 (1993) 567-576
2. Brodsky F.M., and Parham P. Monomorphic anti-HLA-A,B,C monoclonal antibodies detecting molecular subunits and combinatorial determinants. J. Immunol. 128 (1982) 129-135
3. Brunig I., Sommer M., Hatt H., and Bormann J. Dopamine receptor subtypes modulate olfactory bulb gamma-aminobutyric acid type A receptors. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 2456-2460
4. Buchwald B., Toyka K.V., Zielasek J., Weishaupt A., Schweiger S., and Dudel J. Neuromuscular blockade by IgG antibodies from patients with Guillain-Barré syndrome: a macro-patch-clamp study. Ann. Neurol. 44 (1998) 913-922
5. Buchwald B., Weishaupt A., Toyka K.V., and Dudel J. Pre- and postsynaptic blockade of neuromuscular transmission by Miller-Fisher syndrome IgG at mouse motor nerve terminals. Eur. J. Neurosci. 10 (1998) 281-290
6. Buchwald B., Bufler J., Carpo M., Heidenreich F., Pitz R., Dudel J., Nobile-Orazio E., and Toyka K.V. Combined pre- and postsynaptic action of IgG antibodies in Miller Fisher syndrome. Neurology 56 (2001) 67-74
7. Dudel J. Calcium dependence of quantal release triggered by graded depolarization pulses to nerve terminals on crayfish and frog muscle. Pflugers Arch. 415 (1989) 289-298
8. Gong Y., Tagawa Y., Lunn M.P., Laroy W., Heffer-Lauc M., Li C.Y., Griffin J.W., Schnaar R.L., and Sheikh K.A. Localization of major gangliosides in the PNS: implications for immune neuropathies. Brain 125 (2002) 2491-2506
9. Goodfellow J.A., Bowes T., Sheikh K., Odaka M., Halstead S.K., Humphreys P.D., Wagner E.R., Yuki N., Furukawa K., Furukawa K., Plomp J.J., and Willison H.J. Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy. J. Neurosci. 25 (2005) 1620-1628
10. Goodyear C.S., O'Hanlon G.M., Plomp J.J., Wagner E.R., Morrison I., Veitch J., Cochrane L., Bullens R.W., Molenaar P.C., Conner J., and Willison H.J. Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations. [published erratum appears in J. Clin. Invest., 1999 Dec; 104 (12): 1771]. J. Clin. Invest. 104 (1999) 697-708
11. Griffin J.W., Li C.Y., Ho T.W., Xue P., Macko C., Cornblath D.R., Gao C.Y., Yang C., Tian M., Mishu B., McKhann G.M., and Asbury A.K. Guillain-Barré syndrome in northern China: the spectrum of neuropathologic changes in clinically defined cases. Brain 118 (1995) 577-595
12. Griffin J.W., Li C.Y., Macko C., Ho T.W., Hsieh S.-T., Xue P., Wang F.A., Cornblath D.R., McKhann G.M., and Asbury A.K. Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome. J. Neurocytol. 25 (1996) 33-51
13. Hafer-Macko C., Hsieh S.-T., Li C.Y., Ho T.W., Sheikh K., Cornblath D.R., McKhann G.M., Asbury A.K., and Griffin J.W. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann. Neurol. 40 (1996) 635-644
14. Hafer-Macko C., Sheikh K.A., Li C.Y., Ho T.W., Cornblath D.R., McKhann G.M., Asbury A.K., and Griffin J.W. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann. Neurol. 39 (1996) 625-635
15. Halstead S.K., Morrison I., O'Hanlon G.M., Humphreys P.D., Goodfellow J.A., Plomp J.J., and Willison H.J. Anti-disialosyl antibodies mediate selective neuronal or Schwann cell injury at mouse neuromuscular junctions. Glia 52 (2005) 177-189
16. Hartung H.-P., Pollard J.D., Harvey G.K., and Toyka K.V. Immunopathogenesis and treatment of the Guillain-Barré syndrome: Part I. Muscle Nerve 18 (1995) 137-153
17. Ho T.W., Hsieh S.T., Nachamkin I., Willison H.J., Sheikh K., Kiehlbauch J., Flanigan K., McArthur J.C., Cornblath D.R., McKhann G.M., and Griffin J.W. Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection. [see comments]. Neurology 48 (1997) 717-724
18. Hughes R.A., Hadden R.D., Gregson N.A., and Smith K.J. Pathogenesis of Guillain-Barré syndrome. J. Neuroimmunol. 100 (1999) 74-97
19. Isaacson J.S., and Strowbridge B.W. Olfactory reciprocal synapses: dendritic signaling in the CNS. Neuron 20 (1998) 749-761
20. Krampfl K., Mohammadi B., Buchwald B., Jahn K., Dengler R., Toyka K.V., and Bufler J. IgG from patients with Guillain-Barré syndrome interact with nicotinic acetylcholine receptor channels. Muscle Nerve 27 (2003) 435-441
21. Kuwabara S., Yuki N., Koga M., Hattori T., Matsuura D., Miyake M., and Noda M. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome. Ann. Neurol. 44 (1998) 202-208
22. Kuwabara S., Ogawara K., Sung J.Y., Mori M., Kanai K., Hattori T., Yuki N., Lin C.S.Y., Burke D., and Bostock H. Differences in membrane properties of axonal and demyelinating Guillain-Barré syndromes. Ann. Neurol. 52 (2002) 180-187
23. Kuwabara S., Ogawara K., Misawa S., Koga M., Mori M., Hiraga A., Kanesaka T., Hattori T., and Yuki N. Does Campylobacter jejuni infection elicit "demyelinating" Guillain-Barré syndrome?. Neurology 63 (2004) 529-533
24. Latov N. Neuropathy and anti-GM1 antibodies. Ann. Neurol. 27 (1990) S41-S43 (Suppl)
25. Lunn M.P., Johnson L.A., Fromholt S.E., Itonori S., Huang J., Vyas A.A., Hildreth J.E., Griffin J.W., Schnaar R.L., and Sheikh K.A. High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: reexamination of GD1a immunolocalization. J. Neurochem. 75 (2000) 404-412
26. McKhann G.M., Cornblath D.R., Ho T.W., Li C.Y., Bai A.Y., Wu H.S., Yei Q.F., Zhang W.C., Zhaori Z., Jiang Z., Griffin J.W., and Asbury A.K. Clinical and electrophysiological aspects of acute paralytic disease of children and young adults in northern China. Lancet 338 (1991) 593-597
27. McKhann G.M., Cornblath D.R., Griffin J.W., Ho T.W., Li C.Y., Jiang Z., Wu H.S., Zhaori G., Liu Y., Jou L.P., Liu T.C., Gao C.Y., Mao J.Y., Blaser M.J., Mishu B., and Asbury A.K. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann. Neurol. 33 (1993) 333-342
28. Miyazaki T., Kusunoki S., Kaida K., Shiina M., and Kanazawa I. Guillain-Barré syndrome associated with IgG monospecific to ganglioside GD1b. Neurology 56 (2001) 1227-1229
29. O'Hanlon G.M., Humphreys P.D., Goldman R.S., Halstead S.K., Bullens R.W., Plomp J.J., Ushkaryov Y., and Willison H.J. Calpain inhibitors protect against axonal degeneration in a model of anti-ganglioside antibody-mediated motor nerve terminal injury. Brain 126 (2003) 2497-2509
30. Ropper A.H., Wijdicks E.F.M., and Truax B.T. Guillain-Barré Syndrome (1991)
31. Santafe M.M., Sabate M.M., Garcia N., Ortiz N., Lanuza M.A., and Tomas J. Changes in the neuromuscular synapse induced by an antibody against gangliosides. Ann. Neurol. 57 (2005) 396-407
32. Schnaar R.L., Fromholt S.E., Gong Y., Vyas A.A., Laroy W., Wayman D.M., Heffer-Lauc M., Ito H., Ishida H., Kiso M., Griffin J.W., and Sheikh K.A. IgG-class mouse monoclonal antibodies to major brain gangliosides. Anal. Biochem. 302 (2002) 276-284
33. Sheikh K.A., Zhang G., Gong Y., Schnaar R.L., and Griffin J.W. An anti-ganglioside antibody-secreting hybridoma induces neuropathy in mice. Ann. Neurol. 56 (2004) 228-239
34. Susuki K., Nishimoto Y., Yamada M., Baba M., Ueda S., Hirata K., and Yuki N. Acute motor axonal neuropathy rabbit model: immune attack on nerve root axons. Ann. Neurol. 54 (2003) 383-388
35. 2+ channel alpha(1B) subunit-deficient mice. Biochem. Genet. 43 (2005) 287-298
36. Willison H.J., and Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain 125 (2002) 2591-2625
37. Willison H.J., Almemar A., Veitch J., and Thrush D. Acute ataxic neuropathy with cross-reactive antibodies to GD1b and GD3 gangliosides. Neurology 44 (1994) 2395-2397
38. Yuki N. Infectious origins of, and molecular mimicry in Guillain-Barré and Fisher syndromes. Lancet, Infect. Dis. 1 (2001) 29-37
39. Yuki N., Yamada M., Koga M., Odaka M., Susuki K., Tagawa Y., Ueda S., Kasama T., Ohnishi A., Hayashi S., Takahashi H., Kamijo M., and Hirata K. Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside. Ann. Neurol. 49 (2001) 712-720
40. Zhang G., Lopez P.H., Li C.Y., Mehta N.R., Griffin J.W., Schnaar R.L., and Sheikh K.A. Anti-ganglioside antibody-mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: implications for immune neuropathies. Brain 127 (2004) 1085-1100